Note 10 - Warrants

12 Months Ended

Sep. 30, 2025

Notes to Financial Statements

Warrants Disclosure [Text Block]

NOTE 10 – WARRANTS

Transactions involving the Company equity-classified warrants for the fiscal years ended September 30, 2025 and 2024 are summarized as follows:

	Number of shares			Weighted-average exercise price		Weighted-average remaining contractual term (in years)		Aggregate intrinsic value (in thousands)
Outstanding at September 30, 2024		6,168			244.06		2.30		-
Granted		-			-		-		-
Exercised		-			-		-		-
Forfeited		(267	)		1,024.38		-		-
Outstanding at September 30, 2025		5,901			208.75		4.07		-
Exercisable at September 30, 2025		5,901		$	208.75		-	$	-

The following table summarizes outstanding common stock purchase warrants as of September 30, 2025:

	Number of shares		Weighted-average exercise price		Expiration
Exercisable at $1346.40 per share		429		1,346.40	December 2025
Exercisable at $1350 per share		409		1,350.00	June 2026
Exercisable at $20.16 per share		5,063		20.16	April 2028
		5,901	$	208.75